AU2003242983A1 - Novel crystalline forms of abacavir sulfate - Google Patents
Novel crystalline forms of abacavir sulfateInfo
- Publication number
- AU2003242983A1 AU2003242983A1 AU2003242983A AU2003242983A AU2003242983A1 AU 2003242983 A1 AU2003242983 A1 AU 2003242983A1 AU 2003242983 A AU2003242983 A AU 2003242983A AU 2003242983 A AU2003242983 A AU 2003242983A AU 2003242983 A1 AU2003242983 A1 AU 2003242983A1
- Authority
- AU
- Australia
- Prior art keywords
- crystalline forms
- novel crystalline
- abacavir sulfate
- abacavir
- sulfate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229960000531 abacavir sulfate Drugs 0.000 title 1
- WMHSRBZIJNQHKT-FFKFEZPRSA-N abacavir sulfate Chemical compound OS(O)(=O)=O.C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1.C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 WMHSRBZIJNQHKT-FFKFEZPRSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2003/000145 WO2004089952A1 (en) | 2003-04-07 | 2003-04-07 | Novel crystalline forms of abacavir sulfate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003242983A1 true AU2003242983A1 (en) | 2004-11-01 |
Family
ID=33156189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003242983A Abandoned AU2003242983A1 (en) | 2003-04-07 | 2003-04-07 | Novel crystalline forms of abacavir sulfate |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003242983A1 (en) |
| WO (1) | WO2004089952A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101396686B1 (en) * | 2006-09-28 | 2014-05-16 | 에스티브 퀴미카 에스.에이. | Process for the preparation of abacavir |
| EP1905772A1 (en) | 2006-09-28 | 2008-04-02 | Esteve Quimica, S.A. | Process for the preparation of abacavir |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003055377A (en) * | 2001-08-16 | 2003-02-26 | Mitsui Chemicals Inc | Method for producing 2-amino-6-cyclopropylamino-9h- purine |
-
2003
- 2003-04-07 WO PCT/IN2003/000145 patent/WO2004089952A1/en not_active Ceased
- 2003-04-07 AU AU2003242983A patent/AU2003242983A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004089952A1 (en) | 2004-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003900810A0 (en) | Method of scheduling | |
| AU2003206803A1 (en) | Production of alkenones | |
| EP1601622A3 (en) | Improved properties of amorphous/partially crystalline coatings | |
| AU2003245029A1 (en) | Novel crystalline forms of donepezil hydrochloride | |
| AU2003245027A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
| AU2003238671A1 (en) | Novel crystalline forms of s-omeprazole magnesium | |
| AU2003232719A1 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| IL172006A0 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| IL165115A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2002367890A1 (en) | Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate | |
| AU2003242983A1 (en) | Novel crystalline forms of abacavir sulfate | |
| AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
| AU2003298725A1 (en) | Preparation of metallotexaphyrins | |
| AU2003243432A1 (en) | Process of making phosphordiamidite compounds | |
| IL165690A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003264861A1 (en) | Novel crystalline forms of celecoxib | |
| AU2003238669A1 (en) | Novel crystalline forms of parecoxib sodium | |
| AU2003238668A1 (en) | Novel crystalline forms of valdecoxib | |
| AU2003223105A1 (en) | Novel crystalline forms of (s)-citalopram oxalate | |
| AU2003299746A1 (en) | Total synthesis of daurichromenic acid | |
| AU2003263582A1 (en) | Process for the manufacture of rofecoxib | |
| AU2003238678A1 (en) | Novel crystalline forms of sumatriptan succinate | |
| AU2003217439A1 (en) | Novel crystalline forms of finasteride | |
| AU2002334411A1 (en) | Production of usppase | |
| AU2002219436A1 (en) | An improved synthesis of ceftiofur intermediate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |